INNOVADERM CRO IS NOW INDERO.

Our Insights

FILTER BY:

Case Study

Systemic Sclerosis Case Study

Case Study

Urticaria Case Study

Case Study

Atopic Dermatitis (AD) Rescue Case Study

Case Study

A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product

Case Study

Plaque Psoriasis Case Study

Case Study

Nimbus Testimonial

Case Study

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)” – An Inmagene Biopharmaceuticals Testimonial

Case Study

Success Story: Support for Vitiligo Pre-IND Submission and FDA Meeting Preparation

Case Study

Testimonial: “Thanks to Indero’s adaptive approach, we sailed through our trial with ease!”

Case Study

Indero, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

Case Study

Generalized Pustular Psoriasis (GPP) Rescue Case Study

Case Study

Hidradenitis Suppurativa (HS) Case Study

Case Study

Palmoplantar Pustulosis (PPP) Case Study

Case Study

Notalgia Paresthetica (NP) Case Study

Case Study

Alopecia Areata (AA) Case Study

Case Study

Atopic Dermatitis (AD) Case Study

Case Study

Acne Case Study

FILTER BY:

News

Dr. Robert Bissonnette to Present at AAD Innovation Academy 2026

News

See You at EULAR 2026 in London

News

Meet Our Team at the European Dermatology Drug Development Summit in Amsterdam

News

Indero is attending the 2026 SID Annual Meeting in Chicago!

News

Sustained Prominence: Indero Presents High‑Impact Clinical Research at AAD Late‑Breaking Sessions

News

Indero to Participate in the DIF Entrepreneur Bootcamp in Denver

News

Indero’s Breakfast Event at the AAD 2026: Navigating Placebo Response in Dermatology Trials

News

Indero Contributes to New British Journal of Dermatology Publication Exploring the Gut–Skin Connection in Chronic Hand Eczema

News

Join Us at AAD 2026 in Denver, Booth #3945!

News

Indero CRO and the World Scleroderma Foundation Announce Strategic Collaboration to Advance Early Therapeutic Intervention in Systemic Sclerosis

News

Join Indero at the AID’s Dermatology Summit in San Francisco!

News

Indero Named Best Employer by Mercer

News

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

News

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

News

Indero is Returning to THE Annual USA Rheumatology Event!

News

Indero Showcasing Dermatology Expertise at EADV Congress in Paris

News

Meet Indero at SCDM 2025

News

Indero at EADV 2025—Supporting Innovation in Dermatology

News

Indero at ESDR 2025—Advancing Skin Science

News

Let’s Connect at the BIO 2025 convention in Boston!

News

Indero is heading to the European Dermatology Drug Development Summit 2025 in Berlin!

News

Join Us at EULAR 2025 in Barcelona!

News

Join Us at the SID Annual Meeting 2025 in San Diego!

News

Indero Marks 40th Study Live with Veeva RTSM

News

Indero’s Leading Role and Experience in Propelling Dermatology Science Forward Showcased Once Again at the AAD 2025

News

Innovaderm Research Rebrands as Indero

News

Dr. Bissonnette to Present ICONIC-LEAD Trial Results at AAD 2025 Late-Breaking Session 1

News

Indero is heading to Orlando, Florida for the AAD and DIF annual meetings!

News

Join Us at the DIF Entrepreneur Bootcamp in Orlando!

News

Itch Insights: Hives & Highlights—Innovaderm’s 6th FREE Breakfast Event at the AAD

News

Innovaderm Research, a dual-focus CRO, Appoints Jeff Smith as New CEO

News

Join Innovaderm at the AID’s Dermatology Summit in San Francisco!

News

Innovaderm’s CMO Will be Chairing the Clinical Outsourcing Group: CRO Summit!

News

Dr. Robert Bissonnette, EY Entrepreneur Of The YearÂź 2024 Finalist

News

Innovaderm Launches a New Web Page Dedicated to its Customized Stand-Alone Biometrics Solutions!

News

Innovaderm is Attending the EULAR Congress for the First Time!

News

“Collaborative Excellence: A Testament to our Shared Success with Innovaderm!” – A Ventyx Biosciences Testimonial

News

Streamline your Drug Development Journey with Indero’s Clinical/Regulatory Consulting Services

News

Innovaderm, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

News

Innovaderm is proudly supporting AID as a Premier sponsor!

News

End-to-end Expertise: Handling the Entire Journey from Conception to Approval

News

Anne Marie Gaulin, Recently Nominated as Executive VP European Expansion

News

Innovaderm’s leading expertise and experience in advancing the science of dermatology is to be featured at the american academy of dermatology (AAD) late breaking session

News

Giving Back to the Community

News

Welcome back, Jason Shuris

News

Trial on Chronic Hand Eczema

News

Innovaderm Bolsters European Presence With The Addition of Operational Capabilities in Poland and Spain

News

Innovaderm is pleased to announce the acquisition of Excelsus Statistics

News

Innovaderm Honoured With a CRO Leadership Award Again This Year

News

Innovaderm manages a study in PPP and beats recruitment timelines

FILTER BY:

Post

Eureka! Insights from EULAR 2026, Rheumatology’s Euro-Bonanza

Post

What Placebo Response Data in Atopic Dermatitis Trials are Actually Telling Us

Post

Placebo Response in Clinical Trials for Hidradenitis Suppurativa

Post

Reflections on SID 2026: Advances in Dermatology Research

Post

Your AAD 2026 Roadmap: 10 High-Impact Sessions to Prioritize in Denver

Post

Building Momentum in Clinical Trial Start‑Up

Post

Top Rheumatology Conferences to Attend

Post

The Strategic Power of Public Relations in Scientific and Technical Industries

Post

Rethinking CRA Oversight

Post

What Sites Look for in Sponsors: A Practical Checklist

Post

Aligning With Patient Advocates in Trials

Post

A Site-Centric Approach to Protocol Usability

Post

Enhancing Representation: Strategies for Patient Centricity in Inclusive Clinical Trials

Post

Successful Clinical Trial Site Management: A Guide for Biotech and Pharmaceutical Sponsors

Post

Rapid Transcriptomics Brings Actionable Data to Early-Phase Topical Trials

Post

Communication is Key to Unlocking Clinical Trial Success

Post

Lessons From a Mercer-Recognized Best Employer

Post

Effective Patient Recruitment Strategies for Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Post

Early Phase Trials: More Than Just Safety

Post

Top Dermatology Conferences to Attend

Post

Key Advantages of APAC for Sponsors

Post

Interview with Dr. Robert Bissonnette: Indero Introduces New Early Phase 1 Model for Topical NCEs, Shortening Study Duration from 8-12 Weeks to ≀3 Days

how to improve patient recruitment in clinical trials
Post

Innovative Approaches to Patient Recruitment in Clinical Trials

Post

The Role of Technology and Innovation in Clinical Trials: A Guide for Biotech and Pharma Sponsors

Post

Key Sessions to Attend at ACR Convergence 2025

Post

Strengthening data integrity in trials with subjective endpoints

Sponsor–Site Partnerships in Clinical Research
Post

RTSM Optimization: Tips for Smooth Operations

Post

EADV 2025’s Sessions You Cannot Miss

Post

Q&A: Strategies for Successful Global Clinical Trial Delivery

clinical outcome assessments in hidradenitis suppurativa
Post

Measuring Success: Navigating the Top 3 Clinical Outcome Assessments in Hidradenitis Suppurativa

Delayed Payments, Diminished Performance
Post

Delayed Payments, Diminished Performance: The Site Perspective

clinical outcome assessments in alopecia areata
Post

Measuring Success: Navigating the Top 3 Clinical Outcome Assessments in Alopecia Areata

Sponsor–Site Partnerships in Clinical Research
Post

Strengthening Sponsor–Site Partnerships in Clinical Research: Keys to Sustained Site Motivation and Operational Success

Building Trust and Long-Term Relationships in Clinical Trials
Post

Building Trust and Long-Term Relationships in Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Post

Accelerating Study Start-Up and Contract Negotiations in Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Post

Reframing Process Improvement in Clinical Trials

Post

The Changing Face of Protocol Design

risk based monitoring in clinical research
Post

From Theory to Practice: Breaking Down Risk-Based Monitoring in Clinical Trials

choose niche contract research organization
Post

Leveraging Specialized Knowledge: The Benefits of Niche CROs

phase 3 clinical trials
Post

Navigating Phase 3 Clinical Trials: A Project Manager’s Guide

patient recruitment in dermatology clinical trials
Post

Patient Recruitment Dynamics in Dermatology Clinical Trials: The Role of Seasonal Changes

clinical trial communication
Post

Streamlining Communication Between Sponsor, CRO, and Sites in Clinical Trials

how to conduct a clinical trial
Post

Exploring the Significance of Prior Indication Experience in Conducting Clinical Trials

investigational new drug application
Post

Navigating the Investigational New Drug Process: Steps to a Successful Application

efficacy in clinical trials
Post

Optimizing Efficacy Assessments in Clinical Trials: Key Strategies and Considerations

Post

Understanding the Changes in ICH E6 (R3) Guideline

clinical trial site selection process
Post

Laying the Foundation: Mastering Site Selection for Effective Clinical Studies

dermatology early phase clinical trial
Post

Innovative Approaches to Study Design in Early Phase Dermatology Trials

integrated trial management system
Post

Streamlining Clinical Trials: The Power of System Integration

EULAR 2025 Highlights
Post

Post-EULAR 2025 Highlights: Innovations in Autoimmune Disease Management

FILTER BY:

White Paper

Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

White Paper

Leveraging Technology in Phase I Clinical Trials

FILTER BY:

Webinar

Navigating Placebo Response in Dermatology Trials – AAD Breakfast Event

Webinar

Challenges of Managing Clinical Trials in Urticaria

Webinar

Updates on Chronic Spontaneous Urticaria

Webinar

Updates on Chronic Inducible Urticaria

Webinar

Exploring the Intersections: Dermatology and Rheumatology Insights

Webinar

Diving into the World of Adaptive Study Design – The Intersection of Statistics and Dermatology in Clinical Trials

Webinar

In-Person Breakfast Event at the AAD – Exploring the Innovation and Research on Alopecia Areata

Webinar

“Clinical Development Strategy that Patients Need and Investors Want” by Dr. Jasmina Jankicevic

Webinar

On the Edge of Dermatology Early Phase Trials

Webinar

Dr. Robert Bissonnette and Dr. Kim Papp on Shaping the Future of Clinical Research

Webinar

In-Person Breakfast Event at the AAD – Spotlight on Hidradenitis Suppurativa

Webinar

Clinical Trials Information System (CTIS)

Webinar

Tips For a Successful Study in Medical Aesthetics

Webinar

Skin Barrier Dysfunction: Atopic Dermatitis and Beyond

Webinar

The Art of Protocol Writing in Dermatology

Webinar

How to Handle Missing Data in Dermatology Trials

Webinar

Non-invasive methods to study molecular biomarkers in the skin: Tape Stripping and Beyond

FILTER BY:

One-Pager

Rheumatology Trial Readiness Checklist

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.